“Access to Medicines in Low- and Middle-Income Countries – Is the agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) to blame?”, GPJ, vol. 25, no. 1, pp. 1–9, Oct. 2024, doi: 10.38159/q1zweb53.